Comparative Performance of Breast Cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests

Geiersbach Katherine B.; Bridge Julia A.; Dolan Michelle; Jennings Lawrence J.; Persons Diane L.; Souers Rhona J.; Tsuchiya Karen D.; Vasalos Patricia H.; Moncur Joel T.

首页> 外文期刊>Archives of pathology & laboratory medicine >Comparative Performance of Breast Cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests

【24h】

Comparative Performance of Breast Cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests

机译：乳腺癌人体表皮生长因子受体2荧光原位杂交和明菲尔德原位杂交的比较表现，对美国病理学家熟练程度研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Context.-Fluorescence in situ hybridization (FISH) and brightfield in situ hybridization (ISH) are 2 clinically approved laboratory methods for detecting ERBB2 (HER2) amplification in breast cancer.

机译：上下文.-原位杂交（鱼类）和原位杂交（ISH）的荧光是2个临床批准的实验室方法，用于检测乳腺癌中的ERBB2（HER2）扩增。

著录项

来源
《Archives of pathology & laboratory medicine》 |2018年第10期|共6页
作者
Geiersbach Katherine B.; Bridge Julia A.; Dolan Michelle; Jennings Lawrence J.; Persons Diane L.; Souers Rhona J.; Tsuchiya Karen D.; Vasalos Patricia H.; Moncur Joel T.;
展开▼
作者单位

Mayo Clin Dept Lab Med &

Pathol Rochester MN USA;

Univ Nebraska Med Ctr Dept Pathol &

Microbiol Omaha NE USA;

Univ Minnesota Med Sch Dept Lab Med &

Pathol Minneapolis MN 55455 USA;

Ann &

Robert H Lurie Childrens Hosp Chicago Dept Pathol Chicago IL 60611 USA;

Univ Kansas Med Ctr Dept Pathol &

Lab Med Kansas City KS 66103 USA;

Coll Amer Pathologists Dept Biostat Northfield IL USA;

Seattle Childrens Hosp Dept Labs Seattle WA USA;

Coll Amer Pathologists Dept Proficiency Testing Northfield IL USA;

Walter Reed Natl Mil Med Ctr Dept Pathol 8901 Wisconsin Ave Bldg 9 Basement Room 0849 Bethesda;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类病理学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparative Performance of Breast Cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests [J] . Geiersbach Katherine B., Bridge Julia A., Dolan Michelle, Archives of pathology & laboratory medicine . 2018,第10期

机译：乳腺癌人体表皮生长因子受体2荧光原位杂交和明菲尔德原位杂交的比较表现，对美国病理学家熟练程度研究
2. Updated 2013 College of American Pathologists/American Society of Clinical Oncology (CAP/ASCO) guideline recommendations for human epidermal growth factor receptor 2 (HER2) fluorescent in situ hybridization (FISH) testing increase HER2 positive and HER2 equivocal breast cancer cases; retrospective study of HER2 FISH results of 836 invasive breast cancers [J] . Singh Kamaljeet, Tantravahi Umadevi, Lomme Michele M., Breast cancer research and treatment. . 2016,第3期

机译：更新的2013年美国病理学家学院/美国临床肿瘤学会（CAP / ASCO）对人表皮生长因子受体2（HER2）荧光原位杂交（FISH）检测的指南建议增加了HER2阳性和HER2模棱两可的乳腺癌病例; 836例浸润性乳腺癌HER2 FISH结果的回顾性研究
3. Assessing the impact of the 2018 American Society of Clinical Oncology/College of American Pathologists recommendations on human epidermal growth factor receptor 2 testing by fluorescence in situ hybridization in breast carcinoma [J] . Virchows Archiv: an international journal of pathology . 2020,第3期

机译：评估2018年美国临床肿瘤学会/美国病理学家学院的影响力对人表皮生长因子受体2在乳腺癌原位杂交中的荧光测试测试
4. Automated cell segmentation and spot detection in fluorescence in situ hybridization staining to assess HER2 status in breast cancer [C] . Şükrü Burak Çetin, Fariba D. Khameneh, Ercan Alp Serteli, Signal Processing and Communications Applications Conference . 2018

机译：荧光原位杂交染色中的自动细胞分割和斑点检测，以评估乳腺癌中HER2的状态
5. Deletions of tumor suppressor genes in human lung cancers: A fluorescence in situ hybridization (FISH) study [D] . Liu, Jun. 1998

机译：人类肺癌中肿瘤抑制基因的缺失：荧光原位杂交（FISH）研究
6. The Human Epidermal Growth Factor Receptor 2 Screening Tests for Breast Cancer Suggested by the New Updated Recommendation of the American Society of Clinical Oncology/College of American Pathologists Will Involve a Rise of the In-Situ Hybridization Tests for the European Laboratories of Pathology [O] . Christian Garbar, Aude-Marie Savoye, Corinne Mascaux, 2014

机译：由美国临床肿瘤学会/美国病理学家学院的最新更新建议所建议的乳腺癌人表皮生长因子受体2筛查试验将涉及欧洲病理学实验室的原位杂交试验
7. Implications of the Updated 2013 American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations on Human Epidermal Growth Factor Receptor 2 Gene Testing Using Immunohistochemistry and Fluorescence In Situ Hybridization for Breast Cancer [O] . Tse Hui Lim, Alvin Soon Tiong Lim, Aye Aye Thike, 2016

机译：美国临床肿瘤学会/美国病理学家学院的含义对人体表皮生长因子受体2基因试验使用免疫组化和荧光原位杂交对乳腺癌的指导建议
8. Fluorescence In Situ Hybridization(FISH) or Other In Situ Hybridization(ISH) Testing of Uterine Cervical Cells to Predict Precancer and Cancer. (Final). [R] . Uhlig, K., Earley, A., Lamont, J., 2013

机译：子宫颈细胞的荧光原位杂交（FIsH）或其他原位杂交（IsH）测试预测癌前病变和癌症。（最后）。

Comparative Performance of Breast Cancer Human Epidermal Growth Factor Receptor 2 Fluorescence In Situ Hybridization and Brightfield In Situ Hybridization on College of American Pathologists Proficiency Tests

摘要

著录项

相似文献

相关主题

期刊订阅